Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 112.51M | 110.84M | 117.06M | 138.83M | 139.60M | 105.12M |
Gross Profit | 51.38M | 49.99M | 46.24M | 54.39M | 52.68M | 40.30M |
EBITDA | 24.64M | 25.05M | -31.29M | 21.02M | 19.22M | 4.57M |
Net Income | 10.04M | 7.85M | -48.67M | 5.43M | 2.84M | -8.81M |
Balance Sheet | ||||||
Total Assets | 73.56M | 71.61M | 77.83M | 136.17M | 140.85M | 138.00M |
Cash, Cash Equivalents and Short-Term Investments | 6.80M | 5.14M | 3.33M | 12.30M | 9.34M | 20.93M |
Total Debt | 3.29M | 3.47M | 14.73M | 13.81M | 16.87M | 11.47M |
Total Liabilities | 19.38M | 21.84M | 36.11M | 34.48M | 42.92M | 36.75M |
Stockholders Equity | 54.18M | 49.77M | 41.72M | 101.69M | 97.93M | 101.25M |
Cash Flow | ||||||
Free Cash Flow | 19.15M | 18.95M | 3.85M | 9.38M | 2.77M | -8.64M |
Operating Cash Flow | 21.69M | 20.64M | 15.46M | 21.15M | 13.33M | -892.00K |
Investing Cash Flow | -7.05M | -7.41M | -11.61M | -11.77M | -23.15M | -31.47M |
Financing Cash Flow | -11.81M | -11.26M | -13.29M | -7.65M | -519.00K | 33.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $99.88M | ― | 21.00% | ― | -0.45% | 94.32% | |
57 Neutral | £4.68B | 8.52 | -61.44% | 5.55% | 33.02% | 4.62% | |
51 Neutral | $63.96M | ― | -13.02% | ― | 9.00% | -215.40% | |
51 Neutral | $63.96M | ― | -13.02% | ― | 9.00% | -215.40% | |
51 Neutral | $60.98M | ― | 84.03% | ― | -17.91% | 83.17% | |
51 Neutral | $60.98M | ― | 84.03% | ― | -17.91% | 83.17% | |
44 Neutral | $91.52M | ― | 78.44% | ― | ― | ― | |
37 Underperform | $58.03M | ― | -55.59% | ― | ― | 65.02% | |
28 Underperform | $59.88M | ― | -2355.27% | ― | -100.00% | 52.65% |
CareCloud announced its inclusion in the Russell Microcap Index as of June 30, 2025, following a 70% rise in its common stock price during the second quarter of 2025. This milestone highlights the company’s growing momentum in the healthcare technology sector, driven by strategic initiatives such as launching an AI Center of Excellence, resuming acquisition activities, and maintaining a strong cash position.
The most recent analyst rating on (CCLD) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on CareCloud stock, see the CCLD Stock Forecast page.
CareCloud held its Annual Meeting of Shareholders on May 27, 2025, in Somerset, New Jersey, where key decisions were made regarding the company’s governance and financial oversight. During the meeting, three directors were elected to the Board, executive compensation was approved, and Rosenberg Rich Baker Berman, P.A. was appointed as the independent registered public accounting firm for the year ending December 31, 2025.
The most recent analyst rating on (CCLD) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on CareCloud stock, see the CCLD Stock Forecast page.
On May 6, 2025, CareCloud reported strong financial results for Q1 2025, with a 6% year-over-year revenue increase to $27.6 million and a GAAP net income of $1.9 million, marking a significant turnaround from a net loss in Q1 2024. The company launched an AI Center of Excellence, completed strategic acquisitions, and converted preferred stock to strengthen cash flow, positioning itself for sustained profitability and growth.
On May 2, 2025, CareCloud announced that its Board of Directors declared monthly cash dividends for its 8.75% Series A and Series B Cumulative Redeemable Perpetual Preferred Stock for May and June 2025. The announcement highlights the company’s continued commitment to providing returns to its shareholders, reflecting its stable financial position and strategic focus on maintaining investor confidence.